Balyasny Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-121,723
| Closed | -$6.2M | – | 2591 |
|
|
2021
Q4 | $6.2M | Sell |
121,723
-43,571
| -26% | -$2.22M | 0.02% | 655 |
|
|
2021
Q3 | $9.22M | Buy |
+165,294
| New | +$9.22M | 0.04% | 511 |
|
|
2019
Q1 | – | Sell |
-28,633
| Closed | -$1.15M | – | 1579 |
|
|
2018
Q4 | $1.15M | Buy |
+28,633
| New | +$1.15M | 0.01% | 761 |
|
|
2015
Q3 | – | Sell |
-7,055
| Closed | -$570K | – | 1226 |
|
|
2015
Q2 | $570K | Buy |
+7,055
| New | +$570K | ﹤0.01% | 611 |
|